City of Yukon v. Purdue Pharma LP et al
Consolidated
Lead case: 1:17-md-02804
Lead case: 1:17-md-02804
| Ohio Northern District Court | |
| Judge: | Dan Aaron Polster |
| Case #: | 1:19-op-45716 |
| Nature of Suit | 360 Torts - Personal Injury - Other Personal Injury |
| Cause | 28:1441 Petition for Removal |
| Case Filed: | Aug 23, 2019 |
| Case in other court: | Oklahoma Western, 5:19-cv-00280 |
| Last checked: Friday Nov 08, 2019 8:14 PM EST |
|
Defendant
Purdue Pharma L.P.
|
Represented By
|
|
Defendant
Mallinckrodt LLC
|
|
|
Defendant
Mallinckrodt PLC
|
|
|
Defendant
McKesson Corp.
|
Represented By
|
|
Defendant
Morris & Dickson Co LLC
|
|
|
Defendant
Mylan Pharmaceuticals, Inc.
781 Chestnut Ridge Road
Morgantown, WV 26505 |
|
|
Defendant
Oklahoma CVS Pharmacy LLC
|
|
|
Defendant
Ortho-McNeil Janssen Pharmaceuticals, Inc.
|
Represented By
|
|
Defendant
Par Pharmaceutical Inc.
|
|
|
Defendant
Physicians Total Care Inc
|
|
|
Defendant
Purdue Frederick Company, Inc.
|
Represented By
|
|
Defendant
Purdue Pharma Inc.
|
Represented By
|
|
Defendant
Keysource Medical, Inc.
|
|
|
Defendant
Quest Pharmaceuticals, Inc.
|
Represented By
|
|
Defendant
SpecGX LLC
|
|
|
Defendant
Teva Pharmaceutical Industries Ltd.
|
|
|
Defendant
Teva Pharmaceuticals USA, Inc.
|
Represented By
|
|
Defendant
MD William Valuck
|
|
|
Defendant
Walgreens Boots Alliance, Inc., also known as Walgreen Co.
|
|
|
Defendant
Watson Laboratories Inc.
|
Represented By
|
|
Defendant
Watson Pharma, Inc.
|
|
|
Defendant
Watson Pharmaceutcals, Inc.
|
|
|
Defendant
Lynn Webster
|
|
|
Defendant
Johnson & Johnson
|
Represented By
|
|
Defendant
Actavis LLC
|
Represented By
|
|
Defendant
Actavis Pharma, Inc.
|
Represented By
|
|
Defendant
Actavis plc
|
|
|
Defendant
Allergan PLC
|
|
|
Defendant
Amerisourcebergen Corp.
|
Represented By
|
|
Defendant
Anda Inc
|
Represented By
|
|
Defendant
Anda Pharmaceuticals, Inc.
|
Represented By
|
|
Defendant
CVS Health Corporation
|
|
|
Defendant
CVS Pharmacy Inc.
|
|
|
Defendant
Cardinal Health Inc.
|
Represented By
|
|
Defendant
Cephalon Inc.
|
Represented By
|
|
Defendant
Endo Health Solutions Inc.
|
Represented By
|
|
Defendant
Endo Pharmaceuticals Inc.
|
Represented By
|
|
Defendant
Perry Fine
|
|
|
Defendant
GCP Pharma LLC
|
|
|
Defendant
Harvard Drug Group LLC The
|
Represented By
|
|
Defendant
Insys Therapeutics, Inc.
|
|
|
Defendant
Janssen Pharmaceutica Inc.
|
Represented By
|
|
Defendant
Janssen Pharmaceuticals Inc.
|
Represented By
|
|
Defendant
Harvey Jenkins
|
|
|
Plaintiff
City of Yukon
|
Represented By
|
| Docket last updated: 08/26/2019 12:22 PM EDT |
| Monday, March 25, 2019 | ||
| 1 | 1
NOTICE OF REMOVAL from Candian County District Court, case number CJ-2019-119 filed by Endo Pharmaceuticals Inc, Endo Health Solutions Inc.(nv) [Transferred from okwd on 8/23/2019.]
|
|
|
Att: 1
Exhibit 1 - JPML Transfer Order,
|
||
|
Att: 2
Exhibit 2 - Yukon Service Packet,
|
||
|
Att: 3
Exhibit 3 - Petition,
|
||
|
Att: 4
Exhibit 4 - Summons issued to Purdue Pharma L.P..,
|
||
|
Att: 5
Exhibit 5 - Summons issued to Purdue Pharma Inc,
|
||
|
Att: 6
Exhibit 6 - Summons issued to The Purdue Frederick Co,
|
||
|
Att: 7
Exhibit 7 - Summons issued to Cephalon Inc,
|
||
|
Att: 8
Exhibit 8 - Summons issued to Teva Pharmaceuticals USA Inc,
|
||
|
Att: 9
Exhibit 9 - Summons issued to Janssen Pharmaceuticals Inc.,
|
||
|
Att: 10
Exhibit 10 - Summons to Johnson & Johnson,
|
||
|
Att: 11
Exhibit 11 - Summons to Ortho-McNeil-Janssen Pharmaceuticals Inc.,
|
||
|
Att: 12
Exhibit 12 - Summons issued to Janssen Pharmaceutica Inc.,
|
||
|
Att: 13
Exhibit 13 - Summons to Endo Health Solutions Inc.,
|
||
|
Att: 14
Exhibit 14 - Summons to Endo Pharmaceuticals Inc.,
|
||
|
Att: 15
Exhibit 15 - Summons to Allergan PLC,
|
||
|
Att: 16
Exhibit 16 - Summons to Actavis PLC,
|
||
|
Att: 17
Exhibit 17 - Summons to Actavis Pharma Inc,
|
||
|
Att: 18
Exhibit 18 - Summons to Watson Pharmaceutical Inc,
|
||
|
Att: 19
Exhibit 19 - Summons issued to Watson Pharma Inc,
|
||
|
Att: 20
Exhibit 20 - Summons issued to Watson Laboratories Inc.,
|
||
|
Att: 21
Exhibit 21 - Summons issued to Actavis LLC,
|
||
|
Att: 22
Exhibit 22 - Summons issued to Mallinckrodt PLC.,
|
||
|
Att: 23
Exhibit 23 - Summons issued to Mallinckrodt LLC,
|
||
|
Att: 24
Exhibit 24 - Summons issued to Insys Therapeutic Inc.,
|
||
|
Att: 25
Exhibit 25 - Summons issued to McKesson Corp,
|
||
|
Att: 26
Exhibit 26 - Summons issued to Cardinal Health Inc,
|
||
|
Att: 27
Exhibit 27 - Summons issued to AmerisourceBergen Corp,
|
||
|
Att: 28
Exhibit 28 - Summons issued to Anda Pharmaceuticals Inc.,
|
||
|
Att: 29
Exhibit 29 - Summons issued to Anda Inc,
|
||
|
Att: 30
Exhibit 30 - Summons issued to Keysource Medical Inc.,
|
||
|
Att: 31
Exhibit 31 - Summons issued to Morris & Dickson Co LLC,
|
||
|
Att: 32
Exhibit 32 - Summons issued to Quest Pharmaceuticals Inc,
|
||
|
Att: 33
Exhibit 33 - Summons issued to The Harvard Drug Group LLC,
|
||
|
Att: 34
Exhibit 34 - Summons issued to Physicians Total Care Inc.,
|
||
|
Att: 35
Exhibit 35 - Summons issued to William Valuck MD,
|
||
|
Att: 36
Exhibit 36 - Summons issued to Harvey Jenkins MD,
|
||
|
Att: 37
Exhibit 37 - Summons issued to Perry Fine MD,
|
||
|
Att: 38
Exhibit 38 - Summons issued to Lynn Webster MD.,
|
||
|
Att: 39
Exhibit 39 - Entry of Appearance for AmerisourceBergen Corp,
|
||
|
Att: 40
Exhibit 40 - Entry of Appearance for McKesson Corp,
|
||
|
Att: 41
Exhibit 41 - Unopposed Motion for Enlargement of Time by McKesson Corp et al,
|
||
|
Att: 42
Exhibit 42 - Entry of Appearance for Cardinal Health Inc,
|
||
|
Att: 43
Exhibit 43 - Entry of Appearance for The Harvard Drug Group LLC.,
|
||
|
Att: 44
Exhibit 44 - Order granting McKesson Corp et al enlargement of time,
|
||
|
Att: 45
Exhibit 45 - State court docket sheet,
|
||
|
Att: 46
Civil Cover Sheet
|
||
| Tuesday, March 26, 2019 | ||
| PAYMENT FOR A CIVIL CASE Filing fee $ 400, receipt number 1087-2890117. (Zschiesche, Raymond) [Transferred from okwd on 8/23/2019.] | ||
| 2 | 2
ENTRY of Appearance by Raymond E Zschiesche on behalf of Endo Health Solutions Inc, Endo Pharmaceuticals Inc (Zschiesche, Raymond) [Transferred from okwd on 8/23/2019.]
|
|
| 3 | 3
DISCLOSURE STATEMENT - CORPORATE by Endo Health Solutions Inc, Endo Pharmaceuticals Inc . (Zschiesche, Raymond) [Transferred from okwd on 8/23/2019.]
|
|
| 4 | 4
ORDER OF RECUSAL. Honorable David L. Russell recused.. Signed by Honorable David L. Russell on 3/26/19. (jw) [Transferred from okwd on 8/23/2019.]
|
|
| 5 | 5
ORDER REASSIGNING CASE. Case reassigned to Honorable Robin J. Cauthron for all further proceedings.. Signed by Honorable David L. Russell on 3/26/19. (jw) [Transferred from okwd on 8/23/2019.]
|
|
| 6 | 6
ORDER OF RECUSAL. Signed by Honorable Robin J. Cauthron on 03/26/2019. (wh) [Transferred from okwd on 8/23/2019.]
|
|
| 7 | 7
ORDER REASSIGNING CASE. Case reassigned to Honorable Stephen P. Friot for all further proceedings. Honorable Robin J. Cauthron no longer assigned to case. Entered at the direction of Honorable Robin J. Cauthron on 03/26/2019. (wh) [Transferred from okwd on 8/23/2019.]
|
|
| Wednesday, March 27, 2019 | ||
| 8 | 8
ENTRY of Appearance by Susan E Huntsman on behalf of Amerisourcebergen Corp (Huntsman, Susan) [Transferred from okwd on 8/23/2019.]
|
|
| 9 | 9
DISCLOSURE STATEMENT - CORPORATE by Amerisourcebergen Corp . (Huntsman, Susan) [Transferred from okwd on 8/23/2019.]
|
|
| 10 | 10
ENTRY of Appearance by D Michael McBride, III on behalf of Amerisourcebergen Corp (McBride, D) [Transferred from okwd on 8/23/2019.]
|
|
| Thursday, March 28, 2019 | ||
| 11 | 11
ENTRY of Appearance by D Todd Riddles on behalf of Quest Pharmaceuticals Inc (Riddles, D) [Transferred from okwd on 8/23/2019.]
|
|
| 12 | 12
DISCLOSURE STATEMENT - CORPORATE by Quest Pharmaceuticals Inc . (Riddles, D) [Transferred from okwd on 8/23/2019.]
|
|
| 13 | 13
UNOPPOSED MOTION for Extension of Time to File Answer re1 Notice of Removal,,,,,,,,,,, by Quest Pharmaceuticals Inc. (Riddles, D) Modified on 3/29/2019 (llg). [Transferred from okwd on 8/23/2019.]
|
|
| Friday, March 29, 2019 | ||
| 14 | 14
ORDER granting13 Defendant Quest Pharmaceuticals Inc's Unopposed Motion to Extend Time to Answer, Move or Otherwise Respond to Petition Under Rule 12. Signed by Honorable Stephen P. Friot on 3/29/2019. (llg) [Transferred from okwd on 8/23/2019.]
|
|
| 15 | 15
ENTRY of Appearance by Ryan A Ray on behalf of Cardinal Health Inc (Ray, Ryan) [Transferred from okwd on 8/23/2019.]
|
|
| 16 | 16
ENTRY of Appearance by Ryan A Ray on behalf of Harvard Drug Group LLC The (Ray, Ryan) [Transferred from okwd on 8/23/2019.]
|
|
| 17 | 17
DISCLOSURE STATEMENT - CORPORATE by Cardinal Health Inc . (Ray, Ryan) [Transferred from okwd on 8/23/2019.]
|
|
| 18 | 18
DISCLOSURE STATEMENT - LLC by Harvard Drug Group LLC The . (Ray, Ryan) [Transferred from okwd on 8/23/2019.]
|
|
| Monday, April 01, 2019 | ||
| 19 | 19
ENTRY of Appearance by John H Sparks on behalf of Janssen Pharmaceutica Inc, Janssen Pharmaceuticals Inc, Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals Inc (Sparks, John) [Transferred from okwd on 8/23/2019.]
|
|
| 20 | 20
ENTRY of Appearance by Michael W Ridgeway on behalf of Janssen Pharmaceutica Inc, Janssen Pharmaceuticals Inc, Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals Inc (Ridgeway, Michael) [Transferred from okwd on 8/23/2019.]
|
|
| 21 | 21
DISCLOSURE STATEMENT - CORPORATE by Janssen Pharmaceutica Inc, Janssen Pharmaceuticals Inc, Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals Inc . (Ridgeway, Michael) [Transferred from okwd on 8/23/2019.]
|
|
| 22 | 22
UNOPPOSED MOTION for Extension of Time of time to file Responsive Pleadings by Janssen Pharmaceutica Inc, Janssen Pharmaceuticals Inc, Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals Inc. (Ridgeway, Michael) [Transferred from okwd on 8/23/2019.]
|
|
| Tuesday, April 02, 2019 | ||
| 23 | 23
ORDER granting22 Defendants Janssen Pharmaceuticals, Inc., Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals, Inc., and Janssen Pharmaceutica, Inc.'s Unopposed Motion for Extension of Time to File Responsive Pleadings. Signed by Honorable Stephen P. Friot on 4/2/2019. (llg) [Transferred from okwd on 8/23/2019.]
|
|
| Wednesday, April 03, 2019 | ||
| 24 | 24
SUPPLEMENTAL NOTICE OF REMOVAL by McKesson Corp.(Campbell, Stuart) Modified on 4/3/2019 (llg). [Transferred from okwd on 8/23/2019.]
|
|
|
Att: 1
Exhibit 1 - Docket,
|
||
|
Att: 2
Exhibit 2 - Petition,
|
||
|
Att: 3
Exhibit 3 - Summonses,
|
||
|
Att: 4
Exhibit 4 - Entry of Appearance (AmerisourceBergen),
|
||
|
Att: 5
Exhibit 5 - Entry of Appearance (McKesson),
|
||
|
Att: 6
Exhibit 6 - Unopposed Motion for Enlargement (McKesson),
|
||
|
Att: 7
Exhibit 7 - Entry of Appearance (Cardinal),
|
||
|
Att: 8
Exhibit 8 - Entry of Appearance (Harvard Drug Group),
|
||
|
Att: 9
Exhibit 9 - Order Granting Motion for Enlargement (McKesson),
|
||
|
Att: 10
Exhibit 10 - Entry of Appearance (Purdue Pharma),
|
||
|
Att: 11
Exhibit 11 - Entry of Appearance (Quest),
|
||
|
Att: 12
Exhibit 12 - Unopposed Motion for Extension (Manufacturers),
|
||
|
Att: 13
Exhibit 13 - Unopposed Motion for Extension (Quest),
|
||
|
Att: 14
Exhibit 14 - Order Granting Motion for Extension (Quest),
|
||
|
Att: 15
Exhibit 15 - Notice of Filing Notice of Removal,
|
||
|
Att: 16
Exhibit 16 - LCvR7.1
|
||
| 25 | 25
ENTRY of Appearance by Stuart D Campbell on behalf of McKesson Corp (Campbell, Stuart) [Transferred from okwd on 8/23/2019.]
|
|
| 26 | 26
DISCLOSURE STATEMENT - CORPORATE by McKesson Corp . (Campbell, Stuart) [Transferred from okwd on 8/23/2019.]
|
|
| Friday, April 05, 2019 | ||
| 27 | 27
JOINT MOTION for Extension of Time to File Answer Move or Otherwise Respond to Petition Under Rule 12 by Amerisourcebergen Corp, Cardinal Health Inc, Harvard Drug Group LLC The, McKesson Corp. (Campbell, Stuart) Modified on 4/5/2019 (llg).[Transferred from okwd on 8/23/2019.]
|
|
| 28 | 28
ORDER granting27 Defendants McKesson Corporation, Cardinal Health, Inc., AmerisourceBergen Corporation and The Harvard Drug Group, LLC's Unopposed Joint Motion to Extend Time to Answer, Move or Otherwise Respond to Petition Under Rule 12. Signed by Honorable Stephen P. Friot on 4/5/2019. (llg) [Transferred from okwd on 8/23/2019.]
|
|
| Monday, April 08, 2019 | ||
| 29 | 29
ENTRY of Appearance by Nicholas V Merkley on behalf of Actavis LLC, Actavis Pharma Inc, Cephalon Inc, Teva Pharmaceuticals USA Inc, Watson Laboratories Inc (Merkley, Nicholas) Modified on 4/9/2019 (llg). [Transferred from okwd on 8/23/2019.]
|
|
| 30 | 30
ENTRY of Appearance by Ashley E Quinn on behalf of Actavis LLC, Actavis Pharma Inc, Cephalon Inc, Teva Pharmaceuticals USA Inc, Watson Laboratories Inc (Quinn, Ashley) Modified on 4/9/2019 (llg). [Transferred from okwd on 8/23/2019.]
|
|
| 31 | 31
ENTRY of Appearance by Robert G McCampbell on behalf of Actavis LLC, Actavis Pharma Inc, Cephalon Inc, Teva Pharmaceuticals USA Inc, Watson Laboratories Inc (McCampbell, Robert) [Transferred from okwd on 8/23/2019.]
|
|
| 32 | 32
DISCLOSURE STATEMENT - CORPORATE by Actavis LLC, Actavis Pharma Inc, Cephalon Inc, Teva Pharmaceuticals USA Inc, Watson Laboratories Inc . (McCampbell, Robert) [Transferred from okwd on 8/23/2019.]
|
|
| Tuesday, April 09, 2019 | ||
| Docket Annotation: The docket text for doc. nos. 29 and 30 has been corrected to reflect that the Entries of Appearance were filed on behalf of Teva Pharmaceuticals USA Inc, as opposed to Teva Pharmaceutical Industries Ltd. (llg) [Transferred from okwd on 8/23/2019.] | ||
| 33 | 33
MOTION to Remand by Yukon City of.(Court, Todd) [Transferred from okwd on 8/23/2019.]
|
|
|
Att: 1
Exhibit 1 - Trotter v. Smith et al.,
|
||
|
Att: 2
Exhibit 2 - Adams v. Wyeth
|
||
| Friday, April 12, 2019 | ||
| 34 | 34
ENTRY of Appearance by Sanford C Coats on behalf of The Purdue Frederick Company Inc, Purdue Pharma Inc, Purdue Pharma LP (Coats, Sanford) [Transferred from okwd on 8/23/2019.]
|
|
| 35 | 35
ENTRY of Appearance by Jennifer N Lamirand on behalf of The Purdue Frederick Company Inc, Purdue Pharma Inc, Purdue Pharma LP (Lamirand, Jennifer) [Transferred from okwd on 8/23/2019.]
|
|
| 36 | 36
DISCLOSURE STATEMENT - LLC by Purdue Pharma LP . (Lamirand, Jennifer) [Transferred from okwd on 8/23/2019.]
|
|
| 37 | 37
DISCLOSURE STATEMENT - CORPORATE by Purdue Pharma Inc . (Lamirand, Jennifer) [Transferred from okwd on 8/23/2019.]
|
|
| 38 | 38
DISCLOSURE STATEMENT - CORPORATE by The Purdue Frederick Company Inc . (Lamirand, Jennifer) [Transferred from okwd on 8/23/2019.]
|
|
| 39 | 39
ENTRY of Appearance by Joshua D Burns on behalf of The Purdue Frederick Company Inc, Purdue Pharma Inc, Purdue Pharma LP (Burns, Joshua) [Transferred from okwd on 8/23/2019.]
|
|
| Monday, April 22, 2019 | ||
| 40 | 40
ENTRY of Appearance by Kaylee P Davis-Maddy on behalf of McKesson Corp (Davis-Maddy, Kaylee) [Transferred from okwd on 8/23/2019.]
|
|
| Tuesday, April 30, 2019 | ||
| 41 | 41
JOINT MOTION to Stay Case Proceedings Pending Likely Transfer to Multidistrict Litigation by Amerisourcebergen Corp, Cardinal Health Inc, McKesson Corp.(Campbell, Stuart) [Transferred from okwd on 8/23/2019.]
|
|
|
Att: 1
Exhibit 1 - CTO-87,
|
||
|
Att: 2
Exhibit 2 - Wis Stay Order,
|
||
|
Att: 3
Exhibit 3 - Cal. Stay Order 1,
|
||
|
Att: 4
Exhibit 4 - Ky Stay Order,
|
||
|
Att: 5
Exhibit 5 - 6 County Transfer Order,
|
||
|
Att: 6
Exhibit 6 - 1 County Transfer Order,
|
||
|
Att: 7
Exhibit 7 - Cherokee Nation Transfer Order,
|
||
|
Att: 8
Exhibit 8 - Seminole OK Stay Order,
|
||
|
Att: 9
Exhibit 9 - Delaware OK Stay Order,
|
||
|
Att: 10
Exhibit 10 - Pawnee OK Stay Order,
|
||
|
Att: 11
Exhibit 11 - Osage OK Stay Order,
|
||
|
Att: 12
Exhibit 12 - Portland ME Stay Order,
|
||
|
Att: 13
Exhibit 13 - EDVA Stay Order,
|
||
|
Att: 14
Exhibit 14 - WDVA Stay Order,
|
||
|
Att: 15
Exhibit 15 - Cal Stay Order 2,
|
||
|
Att: 16
Exhibit 16 - Ill. Stay Order 1,
|
||
|
Att: 17
Exhibit 17 - Fla. Deferral Order
|
||
| 42 | 42
RESPONSE in Opposition re33 MOTION to Remand filed by McKesson Corp.(Campbell, Stuart) [Transferred from okwd on 8/23/2019.]
|
|
|
Att: 1
Exhibit 1 - CTO-87,
|
||
|
Att: 2
Exhibit 2 - Statement of Interest,
|
||
|
Att: 3
Exhibit 3 - Withdrawal of Order
|
||
| 43 | 43
RESPONSE in Opposition re33 MOTION to Remand filed by Endo Health Solutions Inc, Endo Pharmaceuticals Inc. (Zschiesche, Raymond) [Transferred from okwd on 8/23/2019.]
|
|
| Tuesday, May 07, 2019 | ||
| 44 | 44
RESPONSE to Motion re41 JOINT MOTION to Stay Case Proceedings Pending Likely Transfer to Multidistrict Litigation filed by Yukon City of.(Court, Todd) [Transferred from okwd on 8/23/2019.]
|
|
|
Att: 1
Exhibit 1 - Order Regarding Remands [#130],
|
||
|
Att: 2
Exhibit 2 - Case Management Order [#232]
|
||
| 45 | 45
REPLY by Plaintiff Yukon City of re33 MOTION to Remand filed by Yukon City of. (Court, Todd) [Transferred from okwd on 8/23/2019.]
|
|
| Tuesday, May 14, 2019 | ||
| 46 | 46
REPLY by Defendants Amerisourcebergen Corp, Cardinal Health Inc, McKesson Corp re41 JOINT MOTION to Stay Case Proceedings Pending Likely Transfer to Multidistrict Litigation filed by Amerisourcebergen Corp, Cardinal Health Inc, McKesson Corp. (Campbell, Stuart) [Transferred from okwd on 8/23/2019.]
|
|
| Wednesday, May 15, 2019 | ||
| 47 | 47
MOTION to Expedite Treatment of Motion to Remand by Yukon City of. (Sill, Matthew) [Transferred from okwd on 8/23/2019.]
|
|
| Friday, May 17, 2019 | ||
| 48 | 48
RESPONSE to Motion re47 MOTION to Expedite Treatment of Motion to Remand (Opposition filed by all Moving Defendants) filed by Endo Health Solutions Inc, Endo Pharmaceuticals Inc.(Zschiesche, Raymond) [Transferred from okwd on 8/23/2019.]
|
|
|
Att: 1
Exhibit 1-List of Cases
|
||
| Wednesday, May 22, 2019 | ||
| 49 | 49
SUPPLEMENT of Authority by Yukon City of.(Sill, Matthew) [Transferred from okwd on 8/23/2019.]
|
|
|
Att: 1
Exhibit A - Memorandum and Order re remand
|
||
| Thursday, May 23, 2019 | ||
| NOTICE from the Court re49 Plaintiff's Notice of Supplemental Authority. Counsel for plaintiff is DIRECTED, in future filings, to comply with the court's ECF Policies & Procedures Manual, Section II.A.4.a. - "Exhibits... shall be clearly labeled with the appropriate exhibit number.... Do not use alphabetical or alpha-numeric designations for exhibits...." Failure to comply in the future may result in filings being stricken. (llg) [Transferred from okwd on 8/23/2019.] | ||
| Monday, June 03, 2019 | ||
| 50 | 50
ENTRY of Appearance by Jeffrey A Curran on behalf of Anda Inc, Anda Pharmaceuticals Inc (Curran, Jeffrey) [Transferred from okwd on 8/23/2019.]
|
|
| 51 | 51
DISCLOSURE STATEMENT - CORPORATE by Anda Inc, Anda Pharmaceuticals Inc . (Curran, Jeffrey) [Transferred from okwd on 8/23/2019.]
|
|
| 52 | 52
MOTION for Extension of Time to File Answer re1 Notice of Removal,,,,,,,,,,, by Anda Inc, Anda Pharmaceuticals Inc. (Curran, Jeffrey) Modified on 6/3/2019 (llg). [Transferred from okwd on 8/23/2019.]
|
|
| 53 | 53
ORDER granting52 Defendants Anda, Inc. and Anda Pharmaceuticals, Inc.'s Unopposed Joint Motion to Extend Time to Answer, Move, or Otherwise Respond to Petition Under Rule 12. Signed by Honorable Stephen P. Friot on 6/3/2019. (llg) [Transferred from okwd on 8/23/2019.]
|
|
| Wednesday, June 19, 2019 | ||
| 54 | 54
NOTICE OF BANKRUPTCY by Insys Therapeutic Inc and Imposition of Automatic Stay (Pierce, Amy) [Transferred from okwd on 8/23/2019.]
|
|
| Tuesday, July 23, 2019 | ||
| 55 | 55
NOTICE of Change of Address by Kaylee P Davis-Maddy (Davis-Maddy, Kaylee) [Transferred from okwd on 8/23/2019.]
|
|
| Thursday, August 01, 2019 | ||
| 56 | 56
CONDITIONAL TRANSFER ORDER transferring case to District of Northern District of Ohio for coordinated or consolidated pretrial proceedings pursuant to 28 USC 1407 and assigned to the Honorable Dan A Polster. Signed by Clerk of the Panel. (ac) [Transferred from okwd on 8/23/2019.]
|
|
| Friday, August 23, 2019 | ||
| 57 | 57
CASE TRANSFERRED IN from District of Oklahoma Western. Case number 5:19-cv-00280. Original file, certified copy of transfer order and docket sheet received.
|
|